Your browser doesn't support javascript.
loading
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Lynch, Kate D; Chapman, Roger W; Keshav, Satish; Montano-Loza, Aldo J; Mason, Andrew L; Kremer, Andreas E; Vetter, Marcel; de Krijger, Manon; Ponsioen, Cyriel Y; Trivedi, Palak; Hirschfield, Gideon; Schramm, Christoph; Liu, Chung Heng; Bowlus, Christopher L; Estes, Derek J; Pratt, Daniel; Hedin, Charlotte; Bergquist, Annika; de Vries, Annemarie C; van der Woude, C Janneke; Yu, Lei; Assis, David N; Boyer, James; Ytting, Henriette; Hallibasic, Emina; Trauner, Michael; Marschall, Hanns-Ulrich; Daretti, Luigi M; Marzioni, Marco; Yimam, Kidist K; Perin, Nicola; Floreani, Annarosa; Beretta-Piccoli, Benedetta Terziroli; Rogers, Jennifer K; Levy, Cynthia.
Afiliação
  • Lynch KD; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Chapman RW; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Keshav S; Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Montano-Loza AJ; Division of Gastroenterology, University of Alberta, Edmonton, Canada.
  • Mason AL; Division of Gastroenterology, University of Alberta, Edmonton, Canada.
  • Kremer AE; Department of Medicine 1, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • Vetter M; Department of Medicine 1, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
  • de Krijger M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Location AMC, Amsterdam, The Netherlands.
  • Ponsioen CY; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, Location AMC, Amsterdam, The Netherlands.
  • Trivedi P; Centre for Liver and Gastroenterology Research, National Institute for Health Research, Birmingham Biomedical Research Centre, Birmingham, United Kingdom; University Hospitals Birmingham, Birmingham, United Kingdom; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, Uni
  • Hirschfield G; Centre for Liver and Gastroenterology Research, National Institute for Health Research, Birmingham Biomedical Research Centre, Birmingham, United Kingdom; University Hospitals Birmingham, Birmingham, United Kingdom; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, Uni
  • Schramm C; First Department of Medicine and Martin Zeitz Centre for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Liu CH; Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, California.
  • Bowlus CL; Division of Gastroenterology and Hepatology, University of California Davis, Sacramento, California.
  • Estes DJ; Division of Hepatology, University of Miami, Miami, Florida.
  • Pratt D; Autoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, Massachusetts.
  • Hedin C; Patient Flow Gastrointestinal Diseases, Patient Area Gastroenterology, Dermatovenerology and Rheumatology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Bergquist A; Centre for Digestive Diseases, Division of Hepatology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • de Vries AC; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Yu L; Liver Care & Transplantation Services, University of Washington Medical Center, Seattle, Washington.
  • Assis DN; Yale Autoimmune and Cholestatic Liver Disease Program, Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut.
  • Boyer J; Yale Autoimmune and Cholestatic Liver Disease Program, Section of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut.
  • Ytting H; Department of Hepatology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Hallibasic E; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University if Vienna, Vienna, Austria.
  • Trauner M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University if Vienna, Vienna, Austria.
  • Marschall HU; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Daretti LM; Clinic of Gastroenterology and Hepatology, Ospedali Riuniti University Hospital, Ancona, Italy.
  • Marzioni M; Clinic of Gastroenterology and Hepatology, Ospedali Riuniti University Hospital, Ancona, Italy.
  • Yimam KK; Division of Hepatology and Liver Transplantation, California Pacific Medical Center, San Francisco, California.
  • Perin N; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Floreani A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Beretta-Piccoli BT; Epatocentro Ticino, Lugano, Switzerland.
  • Rogers JK; Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Levy C; Division of Hepatology, University of Miami, Miami, Florida. Electronic address: clevy@med.miami.edu.
Clin Gastroenterol Hepatol ; 18(1): 179-187.e6, 2020 01.
Article em En | MEDLINE | ID: mdl-31100458
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colangite Esclerosante / Doenças Inflamatórias Intestinais / Integrinas / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colangite Esclerosante / Doenças Inflamatórias Intestinais / Integrinas / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Clin Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido